glp-1 obesity drug news today oct 2025 Agonists Weight Loss Drugs Market Report, 2025-2030 Obesity GLP-1 Market

Grouping was based on blood glucose level (using a minimum of 11.1 mM) and body weight

Louis, United States Zaiyong Zheng, Southwest Medical University, China Updates Copyright 2025 Gong, Li, Shi, Wang, Dai, Chen and Su

Cardiovascular Protection: GLP-1s are proven to lower blood pressure and improve cholesterol levels

10.1016/j.addr.2012.04.005

These parallels further support the need to investigate the therapeutic potential of GLP-1 receptor agonists in diabetic patients with PD, who may benefit from both central and peripheral neuroprotection

have reported that Liraglutide ameliorates mitochondrial dysfunction and prevents neuronal loss in the brain of 5FAD mice (188)